HIGHLIGHTS
- who: Xiaocong Ma and collaborators from the The First Affiliated Hospital of Jinan University, Guangzhou, China have published the research work: Nanomaterial-Based Antivascular Therapy in the Multimodal Treatment of Cancer, in the Journal: Pharmaceutics 2023, 1207 of /2023/
- future: With the continuous advancement of technology and the deepening of research the authors believe that in the near future more combinations of nanodrugs and antivascular drugs will enter the clinic setting and that they will achieve more excellent therapeutic effects achieve the long-term and high-quality survival of tumor patients and bring more hope . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.